ExLibris header image
SFX Logo
Title: The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial
Source:

Plos One [1932-6203] Hernandez, Javier yr:2018


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Vickers, Andrew J. "Finasteride to Prevent Prostate Cancer : Should All Men or Only a High-Risk Subgroup Be Treated?" Journal of clinical oncology 28.7 (2010): 1112-1116. Link to SFX for this item
2. Vaughan, Steven D. "PCPT: Evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancer." Urology 73.5 (2009): 935-939. Link to SFX for this item
3. Rubin, E. "Finding the Right Dose for Cancer Therapeutics-Can We Do Better?" Clinical cancer research 16.4 (2010): 1085-1087. Link to SFX for this item
4. Blackwell, Kimberly L. "Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer." Journal of clinical oncology 28.7 (2010): 1124-30. Link to SFX for this item
5. Crawford, Gerald D. "Reduction in the Risk of Prostate Cancer: Future Directions After the Prostate Cancer Prevention Trial." Urology 75.3 (2009): 502-509. Link to SFX for this item
6. Lilja H, G. "Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years." Journal of clinical oncology 25.4 (2007): 431-436. Link to SFX for this item
7. Burstein, Joyce L. "Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study." Journal of clinical oncology 30.21 (2012): 2585-2592. Link to SFX for this item
8. Miles, David W. "Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer." Journal of clinical oncology 28.20 (2010): 3239-3247. Link to SFX for this item
9. Kristal, Alan R. "Diet, Supplement Use, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial." American Journal of Epidemiology 172.5 (2010): 566-577. Link to SFX for this item
10. Murtola, T L J J. "Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial." The British Journal of Cancer 101.5 (2009): 843-8. Link to Full Text for this item Link to SFX for this item
11. Gleave, M. "The effects of the dual 5α-reductase inhibitor dutasteride on localized prostate cancer-results from a 4-month pre-radical prostatectomy study." The Prostate 66.15 (2006): 1674-85. Link to Full Text for this item Link to SFX for this item
12. Shokoohi, L. "Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia." Indian Journal of Dermatology, Venereology and Leprology 75.1 (2009): 47-51. Link to SFX for this item
13. Kennel, P. "Evaluation of the rodent Hershberger assay using three reference endocrine disrupters (androgen and antiandrogens)." Reproductive toxicology 18.1 (2004): 63-73. Link to SFX for this item
14. Scheinfeld, N. "A review of hormonal therapy for female pattern (androgenic) alopecia." Dermatology online journal 14.3 (2008): 1-1. Link to SFX for this item
15. Knudsen, Erik S. "Targeting the RB-pathway in cancer therapy." Clinical cancer research 16.4 (2010): 1094-1099. Link to SFX for this item
16. Stewart, D. "Equipoise Lost: Ethics, Costs, and the Regulation of Cancer Clinical Research." Journal of clinical oncology 28.17 (2010): 2925-2935. Link to SFX for this item
17. Vickers, Andrew J. "Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: Data from the European randomized study of prostate cancer screening in Gothenburg, Sweden." Cancer 116.11 (2010): 2612-2620. Link to Full Text for this item Link to SFX for this item
18. Gravas, S. "Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH." World Journal of Urology 28.1 (2009): 9-15. Link to SFX for this item
19. Bangma, Chris H. "Re: Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured as age 44 to 50 years." European urology 51.5 (2007): 1439-40. Link to SFX for this item
20. Hamilton RJ, Aronson WJ, Terris MK, Kane CJ, Prest, Robert J. "Limitations of Prostate Specific Antigen Doubling Time Following Biochemical Recurrence After Radical Prostatectomy: Results From the SEARCH Database." The Journal of urology 179.5 (2008): 1785-9. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.